Global Travel Vaccines Market Expected to Reach USD 10.0 Billion by 2033 - IMARC Group

January 13, 2025 | Healthcare

Global Travel Vaccines Market Statistics, Outlook and Regional Analysis 2025-2033

The global travel vaccines market size was valued at USD 4.4 Billion in 2024, and it is expected to reach USD 10.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.36% from 2025 to 2033.

Travel Vaccines Market

To get more information on this market, Request Sample

The increasing popularity of international travel among people across the globe drives the industry expansion. In 2024, more than 1 billion international tourists were chronicled between January and September. As globalization and travel become more accessible, the risk of infection across the world increases. Travelers are going to places with different illnesses, which is further stimulating the demand for vaccines. This trend is also supported by the surge in leisure travel and international students studying abroad. Furthermore, the desire for exotic and unique travel experiences is driving people to visit areas with distinct health concerns, emphasizing the importance of specific immunizations. 

Additionally, the rising government regulations regarding vaccination requirements are propelling the market growth. Also, governments across the globe understand the importance of public health during international travel, which has further surged the demand for these vaccines. The WHO's international health regulations require travelers coming to specific countries to confirm yellow fever vaccination. Furthermore, several governments provide subsidized or free travel vaccines to their residents. In June 2024, Uganda announced that it would require everyone to have yellow fever vaccines, whoever is traveling to and from the country. Also, the authorities of the country have vaccinated more than 12 million people. Furthermore, the residents were offered free-of-cost single-dose vaccines, further propelling the industry’s growth. Besides this, the changing nature of disease patterns is driving the market expansion. Infectious diseases are constantly changing and spreading to new areas, which makes ongoing vaccine research and development essential. Also, diseases like Zika and Ebola have become major concerns for travelers, thereby increasing the need for vaccines.  

Global Travel Vaccines Market Statistics, By Region

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America has a dominance in the market share due to the elevating concerns over health and safety.

North America Travel Vaccines Market Trends:

North America acquires the largest share. The surging concerns among people regarding travel related diseases in the region are stimulating the market growth in the region. Also, the CDC in the United States recommends Mpox vaccination for anyone traveling to countries where clade I Mpox is still being transmitted from person to person, thereby further propelling the industry's growth.

Europe Travel Vaccines Market Trends:

In Europe, the growing focus on research and development of advanced travel vaccines is accelerating the market demand. In addition, various countries, like Germany and the UK, are innovating vaccines for travel-related diseases like dengue. Additionally, the European Medicines Agency (EMA) ensures quality standards, boosting traveler confidence. High outbound tourism rates from Europe to tropical regions also contribute to the growing demand for pre-travel vaccinations.

Asia Pacific Travel Vaccines Market Trends:

The growing middle-class population and the increasing international travel in the Asia Pacific region have supported market demand. In addition, the inflating prevalence of several diseases across India is acting as another significant growth-inducing factor. Furthermore, governments in the region are also actively supporting vaccination programs, which is further stimulating the industry’s growth.

Middle East and Africa Travel Vaccines Market Trends:

The heightened awareness regarding disease prevention in the Middle East and Africa is stimulating the market growth. Saudi Arabia being a popular destination for pilgrimage exposes various infections, further propelling the demand for these vaccines. Also, government initiatives promoting vaccination and stringent travel requirements for disease-prone areas further boost the industry's demand.

Latin America Travel Vaccines Market Trends:

The rising efforts to combat endemic diseases across the Latin America region are propelling the market demand. Moreover, countries like Brazil require vaccination proof for travelers going to high-risk areas. Apart from this, the surging outbound travel from countries like Mexico and Argentina to areas that require vaccination is also supporting the demand for these vaccines.

Top Companies Leading in the Travel Vaccines Industry

Some of the leading travel vaccines market companies include GlaxoSmithKline Pharmaceuticals Limited, Sanofi Pasteur, Merck & Co., Inc., Novartis AG, Pfizer Inc., ALK-Abelló A/S, Bavarian Nordic A/S, Crucell (Subsidiary of Johnson & Johnson), CSL Limited, AstraZeneca PLC, Altimmune, Inc., Abbott Laboratories, Hoffmann-La Roche, Inc., among many others. Sanofi Pasteur invested in a new vaccine manufacturing facility in Toronto, Canada. The investment in a new facility boosted antigen and filler capacity for Sanofi's high dose quadrivalent influenza vaccine.

Global Travel Vaccines Market Segmentation Coverage

  • On the basis of the composition, the market has been divided into mono vaccines and combination vaccines, wherein combination vaccines represented the largest segment. A combination travel vaccine is a single vaccine that includes antigens from various diseases. This minimizes the number of shots required to prevent specific diseases.
  • Based on the disease, the market is categorized into hepatitis A, DPT, yellow fever, typhoid, hepatitis B, measles and mumps, rabies, meningococcal, varicella, Japanese encephalitis, and others, amongst which hepatitis A represented the largest segment. Hepatitis A is a highly contagious infection that can spread due to the consumption of unsafe food, making it a major worry for travelers. Also, Hepatitis A immunization is recommended for those traveling to countries with low sanitation and hygiene standards.

 

Report Features Details
Market Size in 2024 USD 4.4 Billion
Market Forecast in 2033 USD 10.0 Billion
Market Growth Rate 2025-2033 9.36%
Units Billion USD
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
  • Composition
  • Disease
  • Region
Compositions Covered Mono Vaccines, Combination Vaccines
Diseases Covered Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others
Regions Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered GlaxoSmithKline Pharmaceuticals Limited, Sanofi Pasteur, Merck & Co., Inc., Novartis AG, Pfizer Inc., ALK-Abelló A/S, Bavarian Nordic A/S, Crucell (Subsidiary of Johnson & Johnson), CSL Limited, AstraZeneca PLC, Altimmune, Inc., Abbott Laboratories, Hoffmann-La Roche, Inc., etc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Browse IMARC Related Reports on Travel Vaccines Market:

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Travel Vaccines Market Expected to Reach USD 10.0 Billion by 2033 - IMARC Group
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials